Sbd

Autor: Rodrigo Huguet

Autor: Renata Andrade Lima Revista: NEJM Ref: Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes. N Engl J Med. 2022 Sep 29;387(13):1161-1172. doi: 10.1056/NEJMoa2205225.

Autor: Fernando Malerbi Revista: Diabetes Care Ref: TODAY Study Group. Development and Progression of Diabetic Retinopathy in Adolescents and Young Adults With Type 2 Diabetes: Results From the TODAY Study. Diabetes Care. 2021 Sep 16;45(5):1049–55. doi: 10.2337/dc21-1072.

Autor: Claudia Pieper Revista: Clin Child Psychol Psychiatry Ref: A review of risk factors associated with insulin omission for weight loss in type 1 diabetes. Clin Child Psychol Psychiatry. 2021 Jul;26(3):606-616. doi: 10.1177/13591045211026142.

Autor: Rodrigo Huguet Revista: Curr Diab Rep. Ref: Eating Disorders and Diabetes. Curr Diab Rep. 2020 Jun 15;20(8):32. doi: 10.1007/s11892-020-01320-0.

Autor: Augusto Cézar Santomauro Júnior

Autor: Juliana de Paula Peixoto Revista: Diabetologia Ref: 'Exercise snacks' before meals: a novel strategy to improve glycaemic control in individuals with insulin resistance. Diabetologia. 2014 Jul;57(7):1437-45. doi: 10.1007/s00125-014-3244-6.

Autor: Paulo Rizzo Genestreti Revista: J Am Coll Cardiol Ref: Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction: JACC Review Topic of the Week. J Am Coll Cardiol. 2022 May 24;79(20):2058-2068. doi: 10.1016/j.jacc.2022.03.353.

Autor: Jonas Gordilho Souza Revista: Diabetes Care Ref: American Diabetes Association Professional Practice Committee. 13. Older Adults: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022 Jan 1;45(Suppl 1):S195-S207. doi: 10.2337/dc22-S013.

Autor: Mark Barone Ref: - Poster ADA: https://diatribe.org/sites/default/files/ADA%202022%20poster_Person-first%20language%20in%20scientific%20publications_FINAL%20%281%29.pdf?fbclid=IwAR1gUGymNVy8FNEMn_bTvaqji4t956_9lbIYa1db_KTkugeDzfcSD99iy5k - Guia de atualização de linguagem para diabetes, obesidade e outras condições crônicas não transmissíveis: https://www.forumdcnts.org/post/linguagem-importa

Autor: Emerson Cestari Marino Revista: Lancet Diabetes Endocrinol, Nat Med Ref: 1) Pasquel FJ. Management of diabetes and hyperglycaemia in the hospital. Lancet Diabetes Endocrinol. 2021 Mar;9(3):174-188. 2) Kosiborod MN. Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Diabetes Endocrinol. 2021 Sep;9(9):586-594. 3) Voors AA. The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial. Nat Med. 2022 Mar;28(3):568-574.

Autor: Sherida Paz Revista: J Family Med Prim Care Ref: Chowdhury S, Chakraborty PP. Errors of insulin therapy: Real-life experiences from developing world. J Family Med Prim Care 2017;6:724-9.

Autor: Claudia Pieper

Autor: Wellington Santana

Autor: Lenita Zajdenverg

Autor: Lenita Zajdenverg

Autor: Maria Cristina Izar

Autor: Luiz Clemente Rolim

Autor: Fani Malerbi

Autor: Denise Maria Martins Vancea